Toxicologie > Valeurs de référence > Autres valeurs des organismes reconnus
Last update the 30/06/2026| Target | Exposure route | Effect type | Exposure type | Value name | Value | Source | Commentary | Critical effect retained | Status state | Exposure duration | Environment | Exposure source | Factor | Management context | Age dependent adjustments factors | ADAF - Age range | ADAF - Value | ADAF - URL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Population générale | Inhalation | A seuil | Aiguë | REL | 2,5 µg.m-3 | OEHHA (2014) | Subjective ocular irritation | Final | 1 Hour | Air ambiant | ||||||||
| Population générale | Inhalation | A seuil | Sub-chronique | REL | 0,7 µg.m-3 | OEHHA (2014) | Lesions in respiratory epithelium | Final | 8-Hour REL (for repeated 8-hour exposure) | Air ambiant | ||||||||
| Population générale | Inhalation | A seuil | Chronique | RfC | 0,00002 mg.m-3 | US EPA (2003) | Nasal lesions | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | CT | 0,4 µg.m-3 | OMS CICAD (2002) | effets irritants | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | REL | 0,35 µg.m-3 | OEHHA (2014) | Lesions in respiratory epithelium | Final | Air ambiant | |||||||||
| Population générale | Orale | A seuil | Chronique | CT | 1,5 µg.L-1 | OMS CICAD (2002) | Valeur provisoire | 7,5 µg/kg/j absence de lésion intestinale | Provisoire | Eau | ||||||||
| Population générale | Inhalation | A seuil | Aiguë | MRL | 0,007 mg.m-3 | ATSDR (2025) | 0,003 ppm |
Nose and throat irritation and decreased respiratory rate | Final | Air ambiant | 100 | |||||||
| Population générale | Inhalation | A seuil | Sub-chronique | MRL | 0,0009 mg.m-3 | ATSDR (2025) | 0,0004 ppm based on the chronic-duration inhalation MRL |
Nasal respiratory gland metaplasia | Final | Air ambiant | 30 | |||||||
| Population générale | Orale | A seuil | Sub-chronique | MRL | 0,002 mg.kg-1.j-1 | ATSDR (2025) | Forestomach squamous epithelial hyperplasia | Final | 100 | |||||||||
| Population générale | Inhalation | A seuil | Chronique | MRL | 0,0009 mg.m-3 | ATSDR (2025) | 0,0004 ppm |
Nasal respiratory gland metaplasia | Final | Air ambiant | 30 | |||||||
| Population générale | Inhalation | A seuil | Aiguë | ReV | 11 µg.m-3 | TCEQ (2010) | 4,8 ppb | Baisse significative de la fréquence ventilatoire (p<0,01), l’irritation du nez et de la gorge observées après une exposition, à 0,3 ppm pendant 1 heure | Final | Air ambiant |